Date:
10 May
Calling all cancer researchers with a novel target idea
Come and join us to discover more about this unique collaborative initiative, where academics and industry researchers work side by side to fast-track novel ideas for cancer targets into therapeutic or diagnostic antibodies which have the potential to bring real patient benefit. The day will feature a talk by Professor Richard Gilbertson about his experience of collaborating with CMAL, lab tours and a networking break. There will also be opportunities for 1:1 conversations.
Event Details
12.00
Networking lunch and registration
12.30
Welcome to CMAL - Agenda outline and CMAL’s vision
(Maria Groves, Head of CMAL)
What are the benefits of collaborating with CMAL?
(Julie Little, Strategic Alliance Executive)
An insight into the CMAL collaboration experience
(Professor Richard Gilbertson, University of Cambridge)
MedImmune/AstraZeneca's role in supporting CMAL
(AZ representative)
Q & A
14.30
Coffee/Networking session and Lab tours
15.00
1:1 meetings with CMAL
(contact Julie Little if you would like to have a 1:1 session about a putative project with CMAL. Confidentiality agreements can be set up pre discussion) - julie.little@cancer.org.uk
Venue and Location Information:
Cancer Research UK MedImmune Alliance (CMAL)
The Portway Building
Granta Park
Cambridge
CB21 6GS
Event Registration Link: